Minister of Health’s Decision that JAMP is not a “Second Person” Was Reasonable
In its new drug submission for SIMLANDI, a biosimilar containing adalimumab, JAMP Pharma Corporation (“JAMP”) sought approval for three specific presentations: (i) 40 mg/0.4 mL pre-filled syringe; (ii) 40 mg/0.4 mL auto-injector pen; and (iii) 80 mg/0.8 mL pre-filled syringe.
Given that AbbVie did not market the equivalent presentations of HUMIRA (adalimumab) in Canada, in a comprehensive and detailed decision, the Minister of Health (the “Minister”) determined that JAMP was not a “second person” for purposes of subsection 5(1) of the Patented Medicines (Notice of Compliance) Regulations (the “PM(NOC) Regulations”) and was thus not required to address patents listed on the patent register by AbbVie before being issued a Notice of Compliance (“NOC”).
Subsequently, the Minister issued an NOC to JAMP for its three presentations of SIMLANDI.
In AbbVie Corporation et al. v. The Minister of Health and JAMP Pharma Corporation, 2022 FC 1209, Justice Fothergill of the Federal Court dismissed AbbVie’s applications to judicially review the Minister’s decisions, on the basis that the Minister’s decisions were reasonable.
Justice Fothergill observed that the “PM(NOC) Regulations are closely connected with the Minister’s functions, and the Minister has great expertise in their application and interpretation”.
In summary, Justice Fothergill determined that the “Minister’s interpretation of s 5(1) of the PM(NOC) Regulations as applying only to a version of a drug that has a specific drug identification number [DIN] and that is marketed in Canada was reasonable, particularly considering the statutory objective of providing a patent enforcement mechanism only in relation to products that are in fact available to Canadians”.
Authors
Expertise
Insights
-
Intellectual Property
Goodmans Wins Leading IP Law Firm – IP Patents at the Lexology Awards: North America 2024
We are proud to share Goodmans has won Leading IP Law Firm - IP Patents at the Lexology Awards: North America 2024. These awards celebrate outstanding achievements and world class client… -
Intellectual Property
Protecting Heads and the Ideas Inside: Yamaha’s Augmented Reality Helmet
A Yamaha patent application has been published for a new design of an augmented reality (AR) motorcycle helmet. The design introduces transparent lenses, which aim to combine the power of the AR… -
Intellectual Property
Bad Bunny Hops into Legal Battle Over Concert Clips
Bad Bunny has reportedly sued a concertgoer for uploading extensive footage of his Utah concert to YouTube. The legal action, filed in California, marks a rare escalation in disputes typically… -
Intellectual Property
Food for Thought: IP Battle Over Butter Chicken
The Delhi High Court reportedly had its initial hearing of Rupa Gujral and Ors v. Daryaganj Hospitality Private Limited and Ors in early 2024. The plaintiff, a famous restaurant chain, Moti Mahal… -
Intellectual Property
Keeping Up With Counterfeits: Kim Kardashian Sued For Knock-Off Dining Tables
Kim Kardashian and her interior design firm, Clements Design, are reportedly being sued by the Judd Foundation for promoting “cheap knockoffs” of one of Judd’s most renowned designs, a dining table… -
Intellectual Property
Mbappé Attempts to Trademark Soccer Celebration Pose
French soccer star, Kylian Mbappé, has sought trademark protection over a logo depicting his iconic goal celebration. The logo is a black and white image of Mbappé standing with his hands tucked…